Index S&P 500
P/E 48.03
EPS (ttm) 7.76
Insider Own 6.45%
Shs Outstand 381.40M
Perf Week -0.81%
Market Cap 142.28B
Forward P/E 25.08
EPS next Y 14.87
Insider Trans -1.96%
Shs Float 356.95M
Perf Month -3.88%
Income 2.99B
PEG 4.43
EPS next Q 2.72
Inst Own 79.25%
Short Float 1.33%
Perf Quarter 4.40%
Sales 22.59B
P/S 6.30
EPS this Y 10.33%
Inst Trans -0.40%
Short Ratio 3.34
Perf Half Y 2.21%
Book/sh 54.10
P/B 6.89
EPS next Y 10.56%
ROA 7.22%
Short Interest 4.73M
Perf Year 5.48%
Cash/sh 11.77
P/C 31.67
EPS next 5Y 10.84%
ROE 15.26%
52W Range 314.93 - 406.19
Perf YTD 3.56%
Dividend Est. 3.21 (0.86%)
P/FCF 40.80
EPS past 5Y 7.20%
ROI 9.01%
52W High -8.20%
Beta 0.95
Dividend TTM 3.24 (0.87%)
Quick Ratio 1.32
Sales past 5Y 8.96%
Gross Margin 61.52%
52W Low 18.40%
ATR (14) 7.99
Dividend Ex-Date Mar 31, 2025
Current Ratio 1.95
EPS Y/Y TTM -5.74%
Oper. Margin 22.25%
RSI (14) 44.54
Volatility 1.77% 2.22%
Employees 53000
Debt/Eq 0.68
Sales Y/Y TTM 10.23%
Profit Margin 13.25%
Recom 1.82
Target Price 430.76
Option/Short Yes / Yes
LT Debt/Eq 0.61
EPS Q/Q -52.50%
Payout 41.74%
Rel Volume 0.61
Prev Close 374.27
Sales Surprise 1.18%
EPS Surprise 3.57%
Sales Q/Q 10.68%
Earnings Jan 28 AMC
Avg Volume 1.42M
Price 372.87
SMA20 -1.37%
SMA50 -2.87%
SMA200 2.62%
Trades
Volume 865,039
Change -0.37%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-25 Resumed
Citigroup
Buy
$450
Dec-02-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$370 → $445
Sep-10-24 Initiated
Wolfe Research
Outperform
$405
May-30-24 Initiated
Goldman
Neutral
$372
May-22-24 Upgrade
Needham
Hold → Buy
$392
Jan-31-24 Upgrade
Canaccord Genuity
Hold → Buy
$315 → $360
Oct-20-23 Initiated
ROTH MKM
Buy
$345
Sep-05-23 Upgrade
BofA Securities
Neutral → Buy
$310 → $315
Mar-29-23 Initiated
UBS
Neutral
$287
Jan-25-23 Initiated
KeyBanc Capital Markets
Sector Weight
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$240 → $284
Nov-01-22 Downgrade
Canaccord Genuity
Buy → Hold
$225 → $220
Oct-18-22 Initiated
Barclays
Overweight
$239
Oct-12-22 Initiated
Jefferies
Buy
$270
Jul-28-22 Upgrade
Edward Jones
Hold → Buy
Jul-21-22 Downgrade
Deutsche Bank
Buy → Hold
$285 → $205
Jul-11-22 Downgrade
BofA Securities
Buy → Neutral
$215
Apr-13-22 Initiated
Truist
Hold
$296
Mar-16-22 Upgrade
Bernstein
Mkt Perform → Outperform
$288 → $295
Mar-15-22 Resumed
Evercore ISI
Outperform
$284
Show Previous Ratings
Mar-25-25 04:15PM
Mar-22-25 12:31AM
Mar-20-25 09:40AM
09:05AM
08:23AM
11:03AM
Loading…
Mar-19-25 11:03AM
Mar-17-25 07:01AM
Mar-12-25 09:00AM
Mar-11-25 03:59PM
08:03AM
Mar-10-25 12:08PM
Mar-06-25 01:36PM
Mar-05-25 09:45AM
Mar-04-25 08:07AM
Mar-03-25 08:07AM
06:14PM
Loading…
Mar-01-25 06:14PM
Feb-28-25 04:04AM
Feb-26-25 11:18AM
Feb-25-25 06:38AM
Feb-24-25 05:23AM
Feb-20-25 04:49AM
Feb-19-25 08:30AM
Feb-17-25 11:21AM
03:07AM
Feb-16-25 07:07PM
Feb-13-25 05:54PM
08:00AM
Feb-12-25 09:14AM
06:55AM
Feb-10-25 04:05PM
04:04AM
Loading…
04:04AM
Feb-07-25 05:06AM
Feb-05-25 08:00AM
Jan-31-25 04:34PM
03:07PM
02:10AM
Jan-29-25 01:48PM
10:31AM
(Design & Development Today)
08:19AM
(Thomson Reuters StreetEvents)
06:44AM
Jan-28-25 06:00PM
05:15PM
05:11PM
04:35PM
(Investor's Business Daily)
04:29PM
(Associated Press Finance)
04:05PM
04:05PM
04:05PM
Jan-26-25 01:22PM
Jan-23-25 09:15AM
Jan-17-25 04:20PM
Jan-16-25 07:43PM
Jan-14-25 12:25PM
Jan-13-25 02:29PM
(Investor's Business Daily)
09:31AM
Jan-08-25 03:17PM
07:18AM
Jan-07-25 04:10PM
(Investor's Business Daily)
12:49PM
11:16AM
10:31AM
(Design & Development Today)
08:11AM
07:54AM
05:43AM
04:55AM
Jan-06-25 06:09PM
04:08PM
04:04PM
(Investor's Business Daily)
12:48PM
08:00AM
Dec-27-24 10:24AM
Dec-19-24 07:37AM
Dec-18-24 10:22PM
Dec-17-24 08:45AM
08:31AM
Dec-15-24 05:35AM
Dec-12-24 12:28PM
Dec-10-24 08:00AM
Dec-03-24 02:04PM
09:42AM
Dec-02-24 02:29PM
Nov-27-24 11:12AM
Nov-20-24 09:15AM
03:21AM
Nov-19-24 09:05AM
Nov-14-24 09:05AM
Nov-12-24 08:22PM
Nov-10-24 05:52AM
Oct-31-24 08:56PM
07:20AM
01:02AM
Oct-30-24 09:43AM
09:37AM
07:36AM
(Thomson Reuters StreetEvents)
03:13AM
Oct-29-24 05:30PM
05:20PM
04:20PM
(Associated Press Finance)
04:05PM
Oct-24-24 09:15AM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stiles Spencer S Group President Mar 21 '25 Option Exercise 0.00 314 0 68,603 Mar 25 04:45 PM Pierce James Andrew Group President Mar 21 '25 Option Exercise 0.00 314 0 72,561 Mar 25 04:41 PM Menon Viju Group President Mar 21 '25 Option Exercise 0.00 187 0 16,934 Mar 25 04:37 PM Lobo Kevin Chair and CEO Mar 21 '25 Option Exercise 0.00 1,085 0 145,625 Mar 25 04:32 PM Fletcher Robert S VP, Chief Legal Officer Mar 21 '25 Option Exercise 0.00 144 0 15,261 Mar 25 04:28 PM Fink M Kathryn VP, Chief HR Officer Mar 21 '25 Option Exercise 0.00 102 0 14,157 Mar 25 04:24 PM Boehnlein Glenn S VP, Chief Financial Officer Mar 21 '25 Option Exercise 0.00 314 0 18,358 Mar 25 04:20 PM Becker Yin C VP, Chief Corp Affairs Officer Mar 21 '25 Option Exercise 0.00 42 0 34,586 Mar 25 04:11 PM Becker Yin C VP, Chief Corp Affairs Officer Feb 27 '25 Option Exercise 96.64 4,980 481,267 35,729 Feb 27 06:15 PM Golston Allan C. Director Feb 18 '25 Option Exercise 122.51 3,605 441,649 18,500 Feb 19 08:46 PM Golston Allan C. Director Feb 18 '25 Sale 383.07 2,458 941,586 14,895 Feb 19 08:46 PM Allan Golston Director Feb 18 '25 Proposed Sale 382.83 2,458 941,000 Feb 18 03:15 PM Silvernail Andrew K Director Feb 03 '25 Option Exercise 93.06 3,795 353,163 14,705 Feb 04 04:27 PM STRYKER RONDA E Director Jan 30 '25 Option Exercise 93.06 3,795 353,163 7,735 Feb 03 04:44 PM STRYKER RONDA E Director Jan 31 '25 Sale 392.24 201,392 78,993,068 3,642,075 Feb 03 04:44 PM STRYKER RONDA E Director Jan 31 '25 Proposed Sale 389.92 236,000 92,020,000 Feb 03 08:58 AM Stiles Spencer S Group President Jan 29 '25 Option Exercise 93.06 10,210 950,143 60,821 Jan 30 04:45 PM Pierce James Andrew Group President Jan 29 '25 Option Exercise 93.06 9,455 879,882 64,868 Jan 30 04:38 PM Boehnlein Glenn S VP, Chief Financial Officer Dec 31 '24 Option Exercise 122.51 300 36,753 5,331 Jan 02 04:44 PM Boehnlein Glenn S VP, Chief Financial Officer Dec 27 '24 Option Exercise 122.51 2,000 245,020 6,373 Dec 30 04:19 PM Boehnlein Glenn S VP, Chief Financial Officer Nov 18 '24 Option Exercise 122.51 4,500 551,295 7,352 Nov 19 04:36 PM Stiles Spencer S Group President Nov 15 '24 Sale 391.16 514 201,056 50,611 Nov 18 04:58 PM Stiles Spencer S Officer Nov 15 '24 Proposed Sale 389.88 514 200,398 Nov 15 11:39 AM Lobo Kevin Chair and CEO Nov 07 '24 Option Exercise 93.06 156,890 14,600,183 256,917 Nov 08 04:20 PM Lobo Kevin Chair and CEO Nov 07 '24 Sale 368.70 57,313 21,131,479 100,027 Nov 08 04:20 PM Kevin Lobo Officer Nov 07 '24 Proposed Sale 368.15 57,313 21,100,000 Nov 07 04:43 PM STRYKER RONDA E Director Nov 05 '24 Sale 367.37 230,000 84,494,990 3,086,608 Nov 07 04:33 PM Becker Yin C VP, Chief Corp Affairs Officer Nov 05 '24 Option Exercise 96.64 4,980 481,267 33,938 Nov 05 06:13 PM STRYKER RONDA E Director Nov 05 '24 Proposed Sale 365.00 230,000 83,950,000 Nov 05 10:10 AM Fink M Kathryn VP, Chief HR Officer Sep 16 '24 Option Exercise 122.51 7,347 900,081 17,389 Sep 17 06:01 PM Fink M Kathryn VP, Chief HR Officer Sep 17 '24 Sale 366.98 7,347 2,696,186 10,042 Sep 17 06:01 PM Fink M Kathryn VP, Chief HR Officer Sep 13 '24 Sale 370.00 2,121 784,770 10,042 Sep 17 06:01 PM Fink M Kathryn Officer Sep 17 '24 Proposed Sale 371.19 7,347 2,727,133 Sep 17 04:07 PM Fink M Kathryn Officer Sep 13 '24 Proposed Sale 370.00 2,121 784,770 Sep 13 04:06 PM Menon Viju Group President Aug 27 '24 Sale 355.00 600 213,000 9,069 Aug 27 05:22 PM Viju Menon Officer Aug 27 '24 Proposed Sale 355.00 600 213,000 Aug 27 04:04 PM STRYKER RONDA E Director Aug 06 '24 Sale 323.46 190,000 61,457,149 3,316,608 Aug 08 04:23 PM STRYKER RONDA E Director Aug 06 '24 Proposed Sale 322.45 190,000 61,265,500 Aug 06 10:57 AM Boehnlein Glenn S VP, Chief Financial Officer Aug 02 '24 Sale 333.00 20,000 6,660,000 2,852 Aug 02 04:17 PM Glenn Boehnlein Officer Aug 02 '24 Proposed Sale 333.00 20,000 6,659,994 Aug 02 11:43 AM Boehnlein Glenn S VP, Chief Financial Officer Jul 02 '24 Option Exercise 122.51 25,000 3,062,750 40,012 Jul 03 04:33 PM Fletcher Robert S VP, Chief Legal Officer May 22 '24 Sale 332.99 2,007 668,308 8,896 May 23 04:06 PM Boehnlein Glenn S VP, Chief Financial Officer May 15 '24 Sale 327.65 10,000 3,276,516 15,012 May 16 04:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite